Longitudinal Assessment of the Enhanced Liver Fibrosis Score in the Era of Contemporary HIV and Hepatitis C Virus Treatment.
Annelys Roque GardnerYifei MaPeter BacchettiJennifer C PriceMark H KuniholmAudrey L FrenchStephen J GangeAdaora A AdimoraHoward MinkoffSeble KassayeIgho OfotokunWilliam RosenbergAndrea A Z KovacsPhyllis C TienPublished in: The Journal of infectious diseases (2022)
The apparent lack of decline in biomarkers of liver fibrosis beyond 1 year after HCV cure suggests that continued monitoring of liver fibrosis and interventions to mitigate progression in people with HIV after HCV cure remains essential.